Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

News Daily News

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

January 27, 2026

Presentation TCT 2025

First Clinical Experience with Solaris Drug-Eluting (DE) Covered Stent: Primary Endpoint Report of the DEScover Randomized Multicenter Trial on the Safety and Efficacy of Solaris DE in Hemodialysis Patients with AV Fistula and Graft Outflow Stenosis

Presenter: Leonardo de Oliveira Harduin

October 26, 2025

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

News Conference News ESC 2025

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

September 09, 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

News Conference News HRS 2025

Studies Spotlight Safety Concerns With Pulsed-Field Ablation for AF

May 05, 2025

Uncertainties Remain About Same-Day Discharge After AF Ablation

News Conference News EHRA 2025

Uncertainties Remain About Same-Day Discharge After AF Ablation

March 30, 2025

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

News Industry News

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

April 03, 2024

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

March 29, 2024

Large Study Affirms Safety of Pulsed-Field Ablation, Reveals Some Rare Complications

News Conference News AHA 2023

Large Study Affirms Safety of Pulsed-Field Ablation, Reveals Some Rare Complications

November 13, 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

November 01, 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

News Conference News ESC 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

August 27, 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

News Conference News EHRA 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

Michael O'Riordan

April 25, 2023

CAPLA: Adding Posterior Wall Isolation No Help in Ablation for Persistent AF

News Daily News

CAPLA: Adding Posterior Wall Isolation No Help in Ablation for Persistent AF

January 13, 2023

Direct Delivery of Antibiotics to CV Device Pocket Infections Appears Promising

News Daily News

Direct Delivery of Antibiotics to CV Device Pocket Infections Appears Promising

January 09, 2023

News Industry News

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

January 22, 2022

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

July 22, 2021

News Industry News

IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly.

June 24, 2021

First-line Ablation With Cryoballoon Gains Support From STOP AF First

News Conference News ESC 2020

First-line Ablation With Cryoballoon Gains Support From STOP AF First

September 02, 2020

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

August 21, 2020

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

November 06, 2019

Update on ROX Trial Program (AV Fistula Creation)

Presentation TCT 2019

Update on ROX Trial Program (AV Fistula Creation)

Presenter: Melvin Lobo

September 28, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.